Chicago-Land, Illinois


Email Chad Finley
Chad Finley
Chad Finley
Attorney • (888) 508-6752

Low T Lawsuits Number More than 1,300

Comments Off

The FDA approved the use of testosterone replacement products only for men who don’t produce enough testosterone because of a medical condition called hypogonadism, although doctors are free to prescribe the medications on an off-label basis if men tested low for testosterone levels. But, according to testosterone treatment lawyers, the lawsuits allege that the drug companies took their marketing way beyond that.

According to Forbes, consumer directed advertisements attributed symptoms like fatigue, low energy, reduced sex drive, and lack of focus to a condition they called “Low-T,” and offered testosterone replacement drugs as anti-aging solutions, despite the fact that age-related hypogonadism has never been established as a disease.

Testosterone Therapy Studies 

Several recent studies have raised concerns regarding testosterone-related heart attack and stroke: 

  • A 2013 study published in the Journal of the American Medical Association concluded that older men using testosterone after receiving a coronary angiography were more likely to suffer heart attacks, strokes, and death than those who did not take the drugs.
  • In 2014, the FDA announced an investigation into the risk of stroke, heart attack, and death in men taking testosterone products and later that same year, began to require all manufacturers to include a general warning about testosterone and the risk of blood clots on their labels.
  • In 2015, the FDA announced a labeling requirement ordering drug makers to warn that testosterone products may increase the risks of heart attacks and strokes.

The plaintiffs in the Illinois MDL testosterone therapy lawsuits are typically men who suffered serious side effects, including heart attacks and strokes, after exposure to testosterone replacement drugs. They allege that they weren’t properly warned of the risks associated with these drugs, and instead were provided with misleading statements about the benefits of Low T medications.